Eterna Therapeutics Inc. (NASDAQ: ERNA)
$2.08
-0.0100 ( -0.48% ) 1.1K
Eterna Therapeutics Inc is a biopharmaceuticals company. The company develops transformational new medicines using various cell engineering technology. It is engaged in developing breakthrough mRNA cell engineering technologies to repair cellular dysfunction and treat a range of therapeutic indications. With its strategic partners, the group is developing nucleic acid and cell therapies that can significantly improve the health outcomes of patients with high unmet medical needs.
Market Data
Open
$2.08
Previous close
$2.09
Volume
1.1K
Market cap
$11.25M
Day range
$1.98 - $2.11
52 week range
$0.84 - $2.96
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
10-q | Quarterly Reports | 76 | Nov 13, 2023 |
8-k | 8K-related | 12 | Nov 01, 2023 |
8-k | 8K-related | 12 | Oct 05, 2023 |
8-k/a | 8K-related | 12 | Sep 26, 2023 |
3 | Insider transactions | 2 | Sep 01, 2023 |
8-k | 8K-related | 12 | Aug 31, 2023 |
4 | Insider transactions | 1 | Aug 25, 2023 |
10-q | Quarterly Reports | 75 | Aug 11, 2023 |
8-k | 8K-related | 13 | Aug 10, 2023 |
4 | Insider transactions | 1 | Aug 10, 2023 |